Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-16

Clinical Trial Update: A Study of Tadalafil in Benign Prostatic Hyperplasia [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for tadalafil in Benign Prostatic Hyperplasia. The study has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Benign Prostatic Hyperplasia | Phase 1 | Status: COMPLETED | Results posted: 2012-05-16